151 related articles for article (PubMed ID: 9225256)
1. Effect of lysophosphatidylcholine on the structure and function of low density lipoproteins.
Korotaeva AA; Cheglakov IB; Morozkin AD; Suslova IV; Prokazova NV
Membr Cell Biol; 1997; 10(5):521-34. PubMed ID: 9225256
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effect of lysophosphatidylcholine and phospholipase A2-treated low density lipoproteins on receptor-dependent regulation of {Ca2+}i in platelets.
Korotaeva AA; Cheglakov IB; Prokazova NV
Platelets; 1997 Jan; 8(1):43-52. PubMed ID: 16793632
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of inhibitory action on platelet activation of a phospholipase A2 isolated from Lachesis muta (Bushmaster) snake venom.
Fuly AL; Machado OL; Alves EW; Carlini CR
Thromb Haemost; 1997 Nov; 78(5):1372-80. PubMed ID: 9408022
[TBL] [Abstract][Full Text] [Related]
4. Inhibition and potentiation of platelet function by lysolecithin.
Joist JH; Dolezel G; Cucuianu MP; Nishizawa EE; Mustard JF
Blood; 1977 Jan; 49(1):101-12. PubMed ID: 830368
[TBL] [Abstract][Full Text] [Related]
5. YD-3, a novel inhibitor of protease-induced platelet activation.
Wu CC; Huang SW; Hwang TL; Kuo SC; Lee FY; Teng CM
Br J Pharmacol; 2000 Jul; 130(6):1289-96. PubMed ID: 10903968
[TBL] [Abstract][Full Text] [Related]
6. Na+/H+ exchange in PAF-stimulated platelets.
Borin ML; Pinelis VG; Azizova OA; Kudinov YV; Markov CM; Cragoe EJ; Khodorov BI
J Lipid Mediat; 1989; 1(5):257-72. PubMed ID: 2562435
[TBL] [Abstract][Full Text] [Related]
7. Effects of the calmodulin antagonists fendiline and calmidazolium on aggregation, secretion of ATP, and internal calcium in washed human platelets.
Lückhoff A; Bohnert M; Busse R
Naunyn Schmiedebergs Arch Pharmacol; 1991 Jan; 343(1):96-101. PubMed ID: 2030746
[TBL] [Abstract][Full Text] [Related]
8. In vitro effects of aprosulate sodium, a novel anticoagulant, on platelet activation: possible mechanism for antiplatelet action.
Sugidachi A; Breiter N; Ogawa T; Asai F; Koike H
Thromb Haemost; 1996 Nov; 76(5):786-90. PubMed ID: 8950791
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine and 7-oxocholesterol modulate Ca2+ signals and inhibit the phosphorylation of endothelial NO synthase and cytosolic phospholipase A2.
Millanvoye-Van Brussel E; Topal G; Brunet A; Do Pham T; Deckert V; Rendu F; David-Dufilho M
Biochem J; 2004 Jun; 380(Pt 2):533-9. PubMed ID: 14992685
[TBL] [Abstract][Full Text] [Related]
10. Oxidative modification of low-density lipoproteins and the inhibition of relaxations mediated by endothelium-derived nitric oxide in rabbit aorta.
Plane F; Bruckdorfer KR; Kerr P; Steuer A; Jacobs M
Br J Pharmacol; 1992 Jan; 105(1):216-22. PubMed ID: 1596684
[TBL] [Abstract][Full Text] [Related]
11. Influence of low density lipoprotein from insulin-dependent diabetic patients on platelet functions.
Rabini RA; Staffolani R; Martarelli D; Fumelli P; Ravaglia F; Dousset N; Curatola G; Mazzanti L
J Clin Endocrinol Metab; 1999 Oct; 84(10):3770-4. PubMed ID: 10523028
[TBL] [Abstract][Full Text] [Related]
12. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis.
Aoki T; Tomiyama Y; Honda S; Senzaki K; Tanaka A; Okubo M; Takahashi F; Takasugi H; Seki J
Thromb Haemost; 1998 Jun; 79(6):1184-90. PubMed ID: 9657446
[TBL] [Abstract][Full Text] [Related]
13. Vitamin E inhibits lysophosphatidylcholine-induced endothelial dysfunction and platelet activation.
Murohara T; Ikeda H; Katoh A; Takajo Y; Otsuka Y; Haramaki N; Imaizumi T
Antioxid Redox Signal; 2002 Oct; 4(5):791-8. PubMed ID: 12470507
[TBL] [Abstract][Full Text] [Related]
14. An essential role for lysophosphatidylcholine in the inhibition of platelet aggregation by secretory phospholipase A2.
Yuan Y; Jackson SP; Newnham HH; Mitchell CA; Salem HH
Blood; 1995 Dec; 86(11):4166-74. PubMed ID: 7492774
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of platelet function by polymorphonuclear leukocytes.
Zatta A; Prosdocimi M; Bertelé V; Bazzoni G; Del Maschio A
J Lab Clin Med; 1990 Nov; 116(5):651-60. PubMed ID: 2146349
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets.
Park WH; Kim HK; Nam KS; Shon YH; Jeon BH; Moon SK; Kim MG; Kim CH
Life Sci; 2004 Nov; 75(25):3063-76. PubMed ID: 15474558
[TBL] [Abstract][Full Text] [Related]
17. Oxidized low-density lipoprotein (LDL) enhances thromboxane A(2) synthesis by platelets, but lysolecithin as a product of LDL oxidation has an inhibitory effect.
Mahfouz MM; Kummerow FA
Prostaglandins Other Lipid Mediat; 2000 Jul; 62(2):183-200. PubMed ID: 10938412
[TBL] [Abstract][Full Text] [Related]
18. Amifostine, a reactive oxigen species scavenger with radiation- and chemo-protective properties, inhibits in vitro platelet activation induced by ADP, collagen or PAF.
Porta C; Maiolo A; Tua A; Grignani G
Haematologica; 2000 Aug; 85(8):820-5. PubMed ID: 10942928
[TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity of apolipoprotein B-100 and binding to LDL-receptor of phospholipase A2-treated low density lipoproteins.
Korotaeva AA; Golovanova NK; Vlasik TN; Yanushevskaya EV; Tsibulsky VP; Yakushkin VV; Tvorogova MG; Morozkin AD; Prokazova NV
Biochemistry (Mosc); 1998 Dec; 63(12):1430-7. PubMed ID: 9916162
[TBL] [Abstract][Full Text] [Related]
20. Picomolar platelet-activating factor mobilizes Ca to change platelet shape without activating phospholipase C or protein kinase C; simultaneous fluorometric measurement of intracellular free Ca concentration and aggregation.
James-Kracke MR; Sexe RB; Shukla SD
J Pharmacol Exp Ther; 1994 Nov; 271(2):824-31. PubMed ID: 7965802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
